Giovanni Caforio, MD
Chief Executive Officer, Bristol-Myers Squibb
On January 20, 2015, Giovanni Caforio was designated chief executive officer by the board of directors, and officially became CEO on May 5, 2015. Prior to becoming CEO, Giovanni served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply. In June 2014, Giovanni was elected to the company’s Board of Directors. Prior to serving as chief operating officer, he served as the company’s chief commercial officer.
“I am honored to have the privilege to lead this great company,” Giovanni said. “I am excited to partner with our very talented team of people at BMS to build on what we’ve accomplished, to deliver on the promise of our innovative portfolio and to continue to make a real difference for our patients.”
As a leader, Giovanni’s focus is on developing talented leaders with the diverse experiences and competencies needed for the continued success of the company.
Giovanni joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, in the Worldwide Medicines Group. In 2001, he assumed added responsibility for Greece and Israel, and then all of South East Europe in 2003. In 2004, he was appointed senior vice president, European Marketing and Brand Commercialization. In 2007, he was named senior vice president, U.S. Oncology. In 2010, he was named senior vice president, Global Commercialization, Oncology and Immunology, before becoming president, U.S., in 2011. In 2013, he was named chief commercial officer. Prior to joining Bristol-Myers Squibb, Giovanni spent 12 years with Abbott Laboratories in a number of leadership positions.
Born and educated in Italy, Giovanni received his M.D. from the University of Rome. In addition to Italian and English, he is fluent in Spanish, French, and Portuguese. He currently resides in New Jersey with his wife and two children.